Govt To Slash MRP Of 3 Anti-Cancer Drugs After Exemption In Customs Duty, GST Rate Cut
New Delhi: After custom duty exemption and a reduction in GST rates, the National Pharmaceutical Pricing Authority (NPPA) has now directed the drug manufacturers to reduce the MRP on three anti-cancer medications, the Ministry of Chemicals and Fertilisers said on Tuesday. The NPPA in an office memorandum dated October 28 directed “the concerned manufacturers to reduce…
